121 Bio Overview

  • Founded
  • 2013

  • Status
  • Out of Business

  • Latest Deal Type
  • Out of Business

121 Bio General Information


Developer of a suite of innovative research tools designed for modification of proteins and cells and innovative cellular immunotherapies. The company's research tools will help drive fundamental new discoveries in protein structure/function and through systematic and deliberate modification of proteins, providing a platform for development of protein-based drugs with enhanced performance.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Other Industries
Other Healthcare
Primary Office
  • 700 Main Street
  • Cambridge, MA 02139
  • United States
+1 (617) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

121 Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Out of Business 01-May-2017 Completed Out of Business
1. Early Stage VC (Series A) 01-Jan-2014 Completed Startup
To view 121 Bio’s complete valuation and funding history, request access »

121 Bio Executive Team (4)

Name Title Board Seat Contact Info
Vanessa Winfield Operations Manager
Gregg Beloff JD Chief Financial Officer
Ramani Varanasi Chief Business Officer
You’re viewing 3 of 4 executive team members. Get the full list »

121 Bio Board Members (4)

Name Representing Role Since
Hidde Ploegh Ph.D Self Co-Founder & Board Member 000 0000
You’re viewing 1 of 4 board members. Get the full list »